D04.8

Clinical Causes: Chronic exposure to ultraviolet (UV) radiation from the sun or tanning beds Genetic predispositions and family history of skin cancers Prolonged exposure to certain chemicals or carcinogens Weakened immune system that hampers skin's ability to repair abnormal cells Previous skin injuries or scars that may alter cellular growth Persistent skin infections or inflammation

Key Symptoms: Persistent, scaly patches or growths on the skin Lesions that may appear as flat or slightly raised spots Changes in the color, size, or shape of existing skin markings Lesions that do not heal or go away over time Sometimes, these areas may be tender or itchy

Diagnosis Path: Diagnosis typically involves a thorough clinical examination by a healthcare professional, who may observe suspicious skin areas. To confirm CIS, a dermatologist may perform a skin biopsy, removing a small sample of tissue for laboratory analysis. This helps distinguish carcinoma in situ from benign skin conditions or invasive cancers. Additional tools such as dermoscopy or imaging may assist in assessing the extent of skin involvement.

Treatment Protocols: Treatment options aim to remove or destroy abnormal cells and prevent progression to invasive skin cancer. Common approaches include: - Topical therapies like chemotherapy or immune response modifiers to target surface lesions - Surgical excision to physically remove affected tissue - Cryotherapy, which uses extreme cold to destroy abnormal cells - Laser therapy to ablate affected skin areas - Photodynamic therapy involving light activation of photosensitive agents The choice of treatment depends on lesion size, location, patient health, and preferences. Regular follow-up with a healthcare provider is crucial to monitor for recurrence or development of new lesions.